Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache
OKP is the FDA product code for Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache, a class II device type, regulated under 21 CFR 882.5808. FDA's definition for this code reads: "Transcranial magnetic stimulator for the treatment of migraine headache delivers brief duration, rapidly alternating, or pulsed, magnetic fields that are externally directed at spatially discrete regions of the brain to induce electric currents for the treatment of migraine headache". As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- OKP
- Device name
- Transcranial Magnetic Stimulator For The Treatment Of Migraine Headache
- FDA definition
- Transcranial magnetic stimulator for the treatment of migraine headache delivers brief duration, rapidly alternating, or pulsed, magnetic fields that are externally directed at spatially discrete regions of the brain to induce electric currents for the treatment of migraine headache.
- Regulation
- 21 CFR 882.5808
- Device class
- Class II
- Review panel
- Neurology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 6
- Ingested recalls
- 0
Clearances, product code OKP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Applicants with the most clearances
Product code OKP| Applicant | Clearances |
|---|---|
| eNeura Inc | 4 |
| Eneura Therapeutics | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
